Cyberounds Logo
December 15, 2019 | LOGIN | REGISTER | HELP | 
email a friend print Bookmark and Share
Pediatric Closed Head Trauma
CME credit is no longer available for this conference.
Kirsten Bechtel, M.D.

Dr. Bechtel is Associate Professor of Pediatrics, Yale University School of Medicine, Attending Physician in the Pediatric Emergency Department and a member of the DART Team (Child Abuse Referral and Evaluation Team) at Yale-New Haven Children's Hospital.

Within the past 12 months, Dr. Bechtel reports no conflicts of interest.


Release Date: 02/06/2009
Termination Date: 02/06/2012

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • Discuss the demographics of children with abusive and accidental head trauma
  • Discuss the radiation risks in children exposed to computed tomography
  • Discuss the use of biomarkers as a potential means to determine which children are at risk for ICI after CHT and might best benefit from computed tomography
  • List the clinical signs and symptoms of ICI in children after accidental closed head trauma
  • Describe the clinical spectrum of symptoms and signs of abusive head trauma, and its association with other injuries (retinal, skeletal)
  • Discuss the neurological outcomes of abusive and accidental head trauma.

 
This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
 
Please click below to accept the terms of this CME activity